Dubuque Bank & Trust CO Gilead Sciences, Inc. Transaction History

Dubuque Bank & Trust CO

$733 Million
Q3 2023

A detailed history of Dubuque Bank & Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Dubuque Bank & Trust CO holds 3,257 shares of GILD stock, worth $300,979. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,257

Previous 3,257 -0.0%

Holding current value

$300,979

Previous $251,000 2.79%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	BUY	$76.01 - $86.7 $34,204 - $39,015	450 Added 16.03%	3,257 $251,000
Q4 2022 Feb 03, 2023	BUY	$62.32 - $89.47 $174,932 - $251,142	2,807 New	2,807 $241,000
Q2 2022 Jul 13, 2022	BUY	$57.72 - $65.01 $192,149 - $216,418	3,329 New	3,329 $206,000
Q1 2022 May 03, 2022	SELL	$57.92 - $72.58 $194,089 - $243,215	-3,351 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$64.88 - $73.64 $4,866 - $5,523	-75 Reduced 2.19%	3,351 $243,000
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $4,196 - $4,527	62 Added 1.84%	3,426 $239,000
Q2 2021 Jul 09, 2021	SELL	$63.47 - $69.35 $110,056 - $120,252	-1,734 Reduced 34.01%	3,364 $232,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $1,440 - $1,643	-24 Reduced 0.47%	5,098 $329,000
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $23,453 - $26,723	414 Added 8.79%	5,122 $298,000
Q2 2020 Jul 24, 2020	SELL	$72.34 - $84.0 $11,863 - $13,776	-164 Reduced 3.37%	4,708 $362,000
Q1 2020 Apr 21, 2020	BUY	$62.63 - $80.22 $305,133 - $390,831	4,872 New	4,872 $365,000
Q2 2019 Jul 10, 2019	SELL	$61.87 - $69.38 $86,370 - $96,854	-1,396 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$71.28 - $78.92 $1,069 - $1,183	-15 Reduced 1.06%	1,396 $108,000
Q2 2018 Jul 17, 2018	SELL	$64.88 - $75.68 $2,335 - $2,724	-36 Reduced 2.49%	1,411 $100,000
Q1 2018 May 10, 2018	SELL	$72.84 - $88.8 $1,602 - $1,953	-22 Reduced 1.5%	1,447 $109,000
Q4 2017 Feb 06, 2018	SELL	$71.15 - $83.52 $25,044 - $29,399	-352 Reduced 19.33%	1,469 $105,000
Q3 2017 Oct 13, 2017	BUY	$72.11 - $85.47 $131,312 - $155,640	1,821	1,821 $148,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dubuque Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Dubuque Bank & Trust CO with notifications on news.

Account

Dubuque Bank & Trust CO Gilead Sciences, Inc. Transaction History